Ekso Bionics (EKSO) to Release Quarterly Earnings on Monday

Ekso Bionics (NASDAQ:EKSO) will be posting its quarterly earnings results after the market closes on Monday, April 29th. Analysts expect Ekso Bionics to post earnings of ($0.16) per share for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.

Ekso Bionics (NASDAQ:EKSO) last released its quarterly earnings results on Monday, March 4th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.11). Ekso Bionics had a negative return on equity of 90.80% and a negative net margin of 83.14%. The company had revenue of $4.85 million for the quarter, compared to analysts’ expectations of $4.80 million. During the same period in the prior year, the business earned ($0.24) EPS. On average, analysts expect Ekso Bionics to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Ekso Bionics Stock Performance

NASDAQ EKSO opened at $1.25 on Friday. The company has a quick ratio of 1.87, a current ratio of 2.49 and a debt-to-equity ratio of 0.38. Ekso Bionics has a 52-week low of $0.62 and a 52-week high of $3.13. The business’s 50-day moving average price is $1.50 and its 200 day moving average price is $1.61. The firm has a market cap of $22.38 million, a P/E ratio of -1.14 and a beta of 1.61.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on the company. HC Wainwright lowered their price target on Ekso Bionics from $10.00 to $9.25 and set a “buy” rating on the stock in a report on Tuesday, March 5th. StockNews.com raised Ekso Bionics from a “sell” rating to a “hold” rating in a report on Thursday, April 4th.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.